Utrophin luciferase knock-in mouse model for in vivo assessment of drug efficacy in preclinical trials for utrophin upregulation

Utrophin luciferase knock-in mouse model for in vivo assessment of drug efficacy in preclinical trials for utrophin upregulation

Bibliographic Details
Main Authors:	Fairclough, R, Davies, K
Format:	Conference item
Published:	2010

Similar Items

Utrophin upregulation in Duchenne muscular dystrophy.
by: Hirst, R, et al.
Published: (2005)

Utrophin upregulation in DMD therapy: current status and new tools for the future
by: Fairclough, R, et al.
Published: (2011)

Identification of new chemical compounds with upregulate utrophin for the therapy of Duchenne muscular dystrophy
by: Fairclough, R, et al.
Published: (2012)

Evaluation of novel compounds for upregulation of utrophin in animal models of Duchenne muscular dystrophy therapy
by: Fairclough, R, et al.
Published: (2008)

Characterisation of utrophin modulator SMT C1100 as a non-competitive inhibitor of firefly luciferase
by: Wilkinson, I, et al.
Published: (2019)

Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.
by: Tinsley, J, et al.
Published: (2011)

Non-toxic ubiquitous overexpression of utrophin in the mdx mouse.
by: Fisher, R, et al.
Published: (2000)

A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours.
by: Sewry, C, et al.
Published: (2005)

Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy.
by: Chancellor, DR, et al.
Published: (2011)

Regulation of utrophin in transgenic mice.
by: Davies, K
Published: (2005)

Understanding the endothelial function of utrophin.
by: Ehmsen, J, et al.
Published: (2002)

Non-toxic ubiquitous over-expression of utrophin in the mdx mouse.
by: Fisher, R, et al.
Published: (2001)

Utrophin upregulation and microRNAs - two avenues of Duchenne muscular dystrophy therapy research
by: Bareja, A
Published: (2011)

Towards the elucidation of the mechanism of action of small molecule upregulators of utrophin using chemical proteomics
by: Vuorinen, A
Published: (2017)

Up-regulation of utrophin alleviates the dystrophic phenotype in the mdx mouse heart
by: Sang, E, et al.
Published: (2000)

Utrophin in the therapy of Duchenne Muscular Dystrophy
by: Potter, A, et al.
Published: (2006)

Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
by: Griffin, J, et al.
Published: (2002)

Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
by: Wakefield, P, et al.
Published: (2000)

Utrophin in therapy of Duchenne muscular distrophy
by: Fisher, R
Published: (2001)

Regulation of utrophin in transgenic mice (multiple letters)
by: Davies, K, et al.
Published: (2005)

The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
by: Perkins, K, et al.
Published: (2002)

Second-generation compound for the modulation of utrophin in the therapy of DMD
by: Guiraud, S, et al.
Published: (2015)

The utrophin and dystrophin genes share similarities in genomic structure.
by: Pearce, M, et al.
Published: (1993)

Immunogold confirmation that utrophin is localized to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle.
by: Culle, M, et al.
Published: (2001)

Future clinical and biomarker development for SMTC1100, the first utrophin modulator to enter clinical trials for Duchenne Muscular Dystrophy (DMD)
by: Tinsley, J, et al.
Published: (2013)

Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.
by: Li, D, et al.
Published: (2010)

Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin
by: Li, D, et al.
Published: (2010)

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
by: Kennedy, T, et al.
Published: (2017)

Confirmation by immunogold labeling that utrophin is localised to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle
by: Cullen, M, et al.
Published: (2001)

Identification of serum protein biomarkers for utrophin based DMD therapy.
by: Guiraud, S, et al.
Published: (2017)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
by: Guiraud, S, et al.
Published: (2019)

Heregulin-induced epigenetic regulation of the utrophin-A promoter.
by: Basu, U, et al.
Published: (2007)

Utrophin up-regulation by an artificial transcription factor in transgenic mice
by: Mattei, E, et al.
Published: (2007)

A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.
by: Weir, A, et al.
Published: (2004)

A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin.
by: Cole, M, et al.
Published: (2002)

ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to beta-dystroglycan.
by: Ishikawa-Sakurai, M, et al.
Published: (2004)

Dystrophin and utrophin influence fiber type composition and post-synaptic membrane structure.
by: Rafael, J, et al.
Published: (2000)

New orally available compounds which modulate utrophin expression for the therapy of Duchenne muscular dystrophy (DMD)
by: Fairclough, R, et al.
Published: (2014)

Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD
by: Guiraud, S, et al.
Published: (2018)

Expression of different isoforms of utrophin in human muscle; potentials for therapy of Duchenne muscular dystrophy
by: Sewry, C, et al.
Published: (2004)